A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
2009

Predictors of Treatment Response in Hepatitis C Patients

Sample size: 400 publication 10 minutes Evidence: moderate

Author Information

Author(s): Idrees Muhammad, Riazuddin Sheikh

Primary Institution: National Centre of Excellence in Molecular Biology, University of the Punjab

Hypothesis

The study aims to identify factors associated with sustained virological response (SVR) in chronic hepatitis C patients treated with interferon alpha and ribavirin.

Conclusion

The best predictors for sustained virological response in chronic hepatitis C patients are rapid virologic response, HCV genotypes 2 and 3, age under 40, and ethnic group Pashtoon.

Supporting Evidence

  • 67% of patients showed end of treatment response.
  • 50.5% achieved sustained virological response.
  • Rapid virologic response was seen in 46.5% of patients.
  • Patients with HCV genotype 2 had the highest SVR rates.

Takeaway

This study found that certain factors can help predict how well hepatitis C treatment will work, especially in younger patients and those with specific virus types.

Methodology

A retrospective review of 731 patients was conducted, with 400 patients treated and followed for treatment response.

Potential Biases

Potential biases may arise from the retrospective nature of the study and the exclusion of patients with certain conditions.

Limitations

The study was limited to patients from specific regions in Pakistan and may not be generalizable to other populations.

Participant Demographics

The study included 400 patients, 280 males and 120 females, with a mean age of 38 years.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI 1.9–3.7

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-230X-9-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication